| Absar Ahmed Qureshi, MD | |
|
2010 Dowlen Road, Beaumont, TX 77706-2525 | |
| (409) 833-9797 | |
| (409) 839-3140 |
| Full Name | Absar Ahmed Qureshi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 2010 Dowlen Road, Beaumont, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134270309 | NPI | - | NPPES |
| 219858201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | N4014 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intrepid Usa Healthcare Services | Nederland, TX | Home health agency |
| Theracare Home Health | San antonio, TX | Home health agency |
| Texas Home Health Skilled Services | Beaumont, TX | Home health agency |
| Baptist Beaumont Hospital | Beaumont, TX | Hospital |
| Christus Southeast Texas- St Elizabeth | Beaumont, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permian Premier Health Services Inc | 8426051293 | 104 |
| Cric Enterprise Llc | 9436498037 | 3 |
News Archive
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient's DNA, according to a study from UT Southwestern Medical Center.
Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.
› Verified 3 days ago
| Entity Name | Southeast Texas Medical Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922001312 PECOS PAC ID: 1658281100 Enrollment ID: O20040405000787 |
News Archive
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient's DNA, according to a study from UT Southwestern Medical Center.
Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.
› Verified 3 days ago
| Entity Name | Permian Premier Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285664763 PECOS PAC ID: 8426051293 Enrollment ID: O20060816000446 |
News Archive
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient's DNA, according to a study from UT Southwestern Medical Center.
Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.
› Verified 3 days ago
| Entity Name | Cric Enterprise Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225500556 PECOS PAC ID: 9436498037 Enrollment ID: O20190226001560 |
News Archive
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient's DNA, according to a study from UT Southwestern Medical Center.
Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Absar Ahmed Qureshi, MD 2929 Calder, Suite 100, Beaumont, TX 77702-1845 Ph: (409) 833-9797 | Absar Ahmed Qureshi, MD 2010 Dowlen Road, Beaumont, TX 77706-2525 Ph: (409) 833-9797 |
News Archive
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient's DNA, according to a study from UT Southwestern Medical Center.
Johns Hopkins' Center for the Epigenetics of Common Human Disease has been chosen as one of four recipients of a $45 million National Institutes of Health (NIH) grant for Centers of Excellence to advance genomics research. The Hopkins Center will receive $16.8 million over five years.
Exiqon A/S, a leader in microRNA analysis products and services, and MultiD Analyses AB, a leader in comprehensive software solutions for qPCR data analysis, today announced a Development and Distribution Agreement incorporating a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform. The agreement allows Exiqon to sell a fully compatible and comprehensive data analysis solution to complete their microRNA qPCR offering.
The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.
› Verified 3 days ago
Dr. Michael Ong, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2965 Harrison St, Ste 211, Beaumont, TX 77702 Phone: 409-899-4231 Fax: 409-899-5264 | |
Dr. James Carlton Robinson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2965 Harrison St, 116, Beaumont, TX 77702 Phone: 409-892-1003 | |
Ahmed A Abdelhakeem, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Baptist Hospitals Of Southeast Texas, 3282 College Street, Beaumont, TX 77701 Phone: 409-212-7463 | |
Dr. Mustafa Ibrahim Musa, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 755 N 11th St, Suite P-5200, Beaumont, TX 77702 Phone: 409-898-2994 Fax: 409-899-5542 | |
Dr. Aamer Janjua, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6345 Ellington Ln, Beaumont, TX 77706 Phone: 409-504-9972 Fax: 409-861-4949 | |
Syed Imtiaz Anwar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3570 College St, Suite 200, Beaumont, TX 77701 Phone: 409-833-9797 Fax: 409-654-6803 | |
Robert C. Hood, M.D.,F.R.C.P.C. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3030 North St, Suite 560, Beaumont, TX 77702 Phone: 409-835-9834 Fax: 409-835-7623 |